James Tsai, MD
- PRESIDENT, NEW YORK EYE & EAR INFIRMARY OF MOUNT SINAI
- PROFESSOR AND SYSTEM CHAIR | Ophthalmology
Specialty:
GlaucomaA graduate of Amherst College and MD alumnus of the Stanford University School of Medicine, Dr. Tsai completed his residency in ophthalmology at the Doheny Eye Institute at the University of Southern California in Los Angeles and glaucoma fellowships at the Bascom Palmer Eye Institute at the University of Miami and at Moorfields Eye Hospital and the Institute of Ophthalmology in London. He also received a master’s degree in business administration from the Owen Graduate School of Management at Vanderbilt University. Dr. Tsai is a fellow of the American Academy of Ophthalmology, the American College of Surgeons and the Royal Society of Medicine in the United Kingdom. He is an elected member of the American Ophthalmological Society, the American Eye Study Club, the New York Ophthalmological Society and the Manhattan Ophthalmological Society. Dr. Tsai currently serves as Chair of the Glaucoma Subcommittee of the National Eye Health Education Program Planning Committee of the National Institute of Health, Chair of the American Academy of Ophthalmology's Global Ophthalmic News & Education Network Advisory Board, Chair of the Medical Advisory Board of the Glaucoma Foundation and Secretary for the English Language Region of the Pan-American Association of Ophthalmology.
Certifications
American Board of Ophthalmology
Clinical Focus
- Glaucoma
- Glaucoma Surgery
Education
MD, Stanford University School of Medicine
Internship, General Practice, Cedars-Sinai Medical Center
Residency, Ophthalmology, USC/Doheny Eye Institute
Fellowship, Glaucoma, Bascomb Palmer Eye Institute
Fellowship, Glaucoma, Moorfields Eye Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Tsai during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- EyeNovia; Smartlens
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Ocutrx
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.